310 related articles for article (PubMed ID: 10653926)
1. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
McPherson R
Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
[TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
3. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate.
Hulley S
Can J Cardiol; 2000 Aug; 16 Suppl E():10E-12E. PubMed ID: 10906618
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
Chew S; Ng SC
Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal hormone replacement therapy and cardiovascular disease.
Chae CU; Ridker PM; Manson JE
Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
[TBL] [Abstract][Full Text] [Related]
7. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
9. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
11. Preserving cardiovascular benefits of hormone replacement therapy.
Bush TL
J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
13. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
15. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
Nevitt MC; Felson DT; Williams EN; Grady D
Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
[TBL] [Abstract][Full Text] [Related]
16. Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen.
Leiter LA
Can J Cardiol; 2000 Aug; 16 Suppl E():13E-16E. PubMed ID: 10906619
[TBL] [Abstract][Full Text] [Related]
17. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]